On October 15, Astera Labs, Inc. fell 5.29% in Regular Trading, trading at $284.74 per share, with turnover of $220 million.
The clearest catalyst remains an event-driven repricing after Northland Securities downgraded the stock to market perform from outperform, while profit-taking pressure continued ahead of the company’s November 3 third-quarter results.
Recent market updates showed the downgrade was still weighing on sentiment across after-hours, overnight and pre-market trading on October 15, even as consensus expectations remained relatively firm. Analysts on average still rate the shares overweight/add, with a mean target price of $416.78, and the market currently expects next-quarter EPS of $0.83. The stock’s weakness also unfolded alongside a broader semiconductor selloff, with major peers including AMD, Intel, NVIDIA, Micron Technology and TSMC all declining.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments